Biomaterials suppliers could be reintroduced into device liability actions under amended HR 872.
This article was originally published in The Gray Sheet
Executive Summary
BIOMATERIALS SUPPLIERS COULD BE REINTRODUCED INTO DEVICE LIABILITY ACTIONS after a finding against a manufacturer, according to an amended version of the "Biomaterials Access Assurance Act of 1997" (HR 872) approved by the House Judiciary/Commercial and Administrative Law Subcommittee Sept. 11.